{"id":"W2081555496","doi":"10.1158/0008-5472.sabcs12-ot1-1-07","title":"Abstract OT1-1-07: Human epidermal growth factor receptor 2 (HER2) suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LTP112515)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Lapatinib; Medicine; Trastuzumab; Metastatic breast cancer; Tolerability; Internal medicine; Discontinuation; Oncology; Breast cancer; Chemotherapy; Adverse effect; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004047216,0.0006231774,0.001107317,0.0003488839,0.0002592227,0.0005029382,0.0006947397,0.0005723002,0.003119301],"category_scores_gemma":[0.0002857952,0.000213687,0.0006092208,0.0003747488,0.0006284093,0.0004867015,0.0003067574,0.001922842,0.0004682585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004374695,"about_ca_system_score_gemma":0.0009181922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008786379,"about_ca_topic_score_gemma":0.001543748,"domain_scores_codex":[0.9997787,0.00005538794,0.00002186875,0.00003948466,0.0000330425,0.0000716465],"domain_scores_gemma":[0.9997748,0.00002661755,0.0000500094,0.00002115505,0.00001117903,0.0001162558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3081803,0.08089214,0.00675376,0.0009572983,0.0006591809,0.000565339,0.0001744615,0.002757083,0.4791621,0.0005451287,0.00536067,0.1139926],"study_design_scores_gemma":[0.1334957,0.7203919,0.01872712,0.00004571544,0.0005842694,0.001026172,0.00009101822,0.00219168,0.1190556,0.0002232035,0.0041166,0.00005117939],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979115,0.0004723657,0.0001512612,0.0001232249,0.0000507565,0.0001982862,0.0003826744,0.00004164387,0.000668209],"genre_scores_gemma":[0.9962084,0.0005098344,0.0004205406,0.0001477763,0.00004875277,0.000279174,0.001214998,0.00001050539,0.001159907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003119301,"threshold_uncertainty_score":0.01043504,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1030231998360531,"score_gpt":0.4488261748900876,"score_spread":0.3458029750540345,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}